Patient expectations of benefit from systemic treatments for metastatic prostate cancer.

At the trend level, there was a greater proportion of men who were married or partnered who believed that systemic therapy was at least a little likely to provide symptom relief vs not at all likely (81% vs 40%, respectively), although this relationship did not reach statistical significance ( P = .06).

also in 111,027 other papers